Marcellusi, A., Bini, C., Fioravanti, L., Ripoli, S., & Morelli, P. (2025). Cost-effectiveness of Brentuximab Vedotin plus chemotherapy as frontline treatment of systemic anaplastic large cell lymphoma in Italy. Global and Regional Health Technology Assessment, 12(1), 106–117. https://doi.org/10.33393/grhta.2025.3306